D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
PUT
Cameco
CCJ
$37.5B
| $34M | 0.02% |
312,900
+150,800
| +93% | +$17.3M |
2021 Q2
19 quarters
|
|
802
CALL
Amgen
AMGN
$223B
| $34M | 0.02% |
96,500
-24,400
| -20% | -$8.7M |
2022 Q4
13 quarters
|
|
803
Royal Caribbean
RCL
$75.3B
| $33.9M | 0.02% |
123,351
-224,986
| -65% | -$67M |
2022 Q4
13 quarters
|
|
804
Moderna
MRNA
$86.3B
| $33.9M | 0.02% |
666,532
-4,516,227
| -87% | -$211M |
2024 Q3
6 quarters
|
|
805
PUT
SLB Ltd
SLB
$72.4B
| $33.7M | 0.02% |
656,100
-779,500
| -54% | -$37.8M |
2013 Q2
51 quarters
|
|
806
The Greenbrier Companies
GBX
$1.22B
| $33.7M | 0.02% |
639,913
+88,151
| +16% | +$4.66M |
2022 Q4
13 quarters
|
|
807
Vistance Networks Inc
VISN
$1.41B
| $33.5M | 0.02% |
1,842,595
-1,692,146
| -48% | -$30.9M |
2021 Q2
19 quarters
|
|
808
GE HealthCare
GEHC
$31.1B
| $33.5M | 0.02% |
470,374
-837,294
| -64% | -$66M |
2023 Q1
12 quarters
|
|
809
PUT
Rocket Lab Corp
RKLB
$41.1B
| $33.4M | 0.02% |
520,600
+268,200
| +106% | +$20.2M |
2025 Q1
4 quarters
|
|
810
Charles River Laboratories
CRL
$14.3B
| $33.4M | 0.02% |
193,483
-237,645
| -55% | -$44.1M |
2025 Q2
3 quarters
|
|
811
CALL
Blackrock
BLK
$165B
| $33.4M | 0.02% |
34,700
+16,100
| +87% | +$16.9M |
2017 Q4
33 quarters
|
|
812
PUT
Intuitive Surgical
ISRG
$149B
| $33.3M | 0.02% |
+72,200
| New | +$36.5M |
2026 Q1
0 quarters
|
|
813
Plexus
PLXS
$6.87B
| $33.2M | 0.02% |
163,947
-41,633
| -20% | -$7.91M |
2013 Q4
49 quarters
|
|
814
Commerce Bancshares
CBSH
$7.79B
| $33.2M | 0.02% |
674,301
+34,027
| +5% | +$1.77M |
2024 Q1
8 quarters
|
|
815
PUT
Manulife Financial
MFC
$71.6B
| $33.1M | 0.02% |
962,500
-1,287,600
| -57% | -$46.3M |
2023 Q3
10 quarters
|
|
816
Dick's Sporting Goods
DKS
$13.6B
| $33.1M | 0.02% |
167,033
-161,796
| -49% | -$32.8M |
2021 Q2
19 quarters
|
|
817
TXNM Energy Inc
TXNM
$6.45B
| $33.1M | 0.02% |
565,921
-856,455
| -60% | -$50.5M |
2025 Q2
3 quarters
|
|
818
Manhattan Associates
MANH
$13B
| $33.1M | 0.02% |
248,485
-25,566
| -9% | -$3.83M |
2020 Q4
21 quarters
|
|
819
PUT
Datadog
DDOG
$102B
| $33.1M | 0.02% |
280,000
-765,100
| -73% | -$94.5M |
2020 Q2
23 quarters
|
|
820
Navitas Semiconductor
NVTS
$2.74B
| $33M | 0.02% |
3,767,604
+3,203,751
| +568% | +$29.5M |
2024 Q4
5 quarters
|
|
821
Interactive Brokers
IBKR
$39.6B
| $33M | 0.02% |
491,508
+466,791
| +1,889% | +$33.3M |
2019 Q4
25 quarters
|
|
822
Valaris
VAL
$5.94B
| $33M | 0.02% |
336,221
+287,160
| +585% | +$22.4M |
2025 Q3
2 quarters
|
|
823
Liquidia Corp
LQDA
$2.4B
| $32.9M | 0.02% |
873,065
-794,317
| -48% | -$29.5M |
2024 Q4
5 quarters
|
|
824
PUT
Intuit
INTU
$80.6B
| $32.9M | 0.02% |
76,100
+25,100
| +49% | +$12M |
2021 Q3
18 quarters
|
|
825
PUT
LyondellBasell Industries
LYB
$19.4B
| $32.9M | 0.02% |
408,100
-25,000
| -6% | -$1.48M |
2024 Q4
5 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.